StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Repare Therapeutics Inc.
NasdaqGS:RPTX
Sector
Industries
Location
Market Cap
USD 61.76 M
Share Price
USD 1.44
Avg Daily Volume
301,490
Change (1 day)
0.00%
Change (1 year)
-54.72%
Change (YTD)
9.92%
Repare Therapeutics Inc. Revenue for the Trailing 12 Months (TTM) ending September 30, 2024: USD 66.52 M
Repare Therapeutics Inc. Revenue is USD 66.52 M for the Trailing 12 Months (TTM) ending September 30, 2024, a 18.19% change year over year. Revenue is the total amount of money generated from the sales of goods or services by a company during a specific period.
-
Repare Therapeutics Inc. Revenue for the Trailing 12 Months (TTM) ending September 30, 2023 was USD 56.28 M, a -53.29% change year over year.
-
Repare Therapeutics Inc. Revenue for the Trailing 12 Months (TTM) ending September 30, 2022 was USD 120.51 M, a 13,945.34% change year over year.
-
Repare Therapeutics Inc. Revenue for the Trailing 12 Months (TTM) ending September 30, 2021 was USD 858.00 K.
-
Repare Therapeutics Inc. Revenue for the Trailing 12 Months (TTM) ending September 30, 2020 was USD 0.00.
Competitors
AbbVie Inc.
USD 189.28
ABBV
-1.47
-0.77%
Novo Nordisk A/S
USD 71.08
NOVO-B.CO
+2.24
3.26%
Roche Holding AG
USD 347.79
RO.SW
+3.30
0.96%
Novartis AG
USD 123.46
NOVN.SW
+2.11
1.74%
Abbott Laboratories
USD 134.44
ABT
+0.33
0.25%
AstraZeneca PLC
USD 140.96
AZN.L
+1.64
1.18%
Merck & Co., Inc.
USD 80.93
MRK
-1.46
-1.77%
Thermo Fisher Scientific Inc.
USD 429.33
TMO
+1.57
0.37%
Amgen Inc.
USD 298.24
AMGN
+1.39
0.47%
Boston Scientific Corporation
USD 104.32
BSX
+0.69
0.67%
Pfizer Inc.
USD 25.38
PFE
+0.06
0.24%
Gilead Sciences, Inc.
USD 111.75
GILD
+0.24
0.21%
Sanofi
USD 98.03
SAN.PA
+1.08
1.11%
Vertex Pharmaceuticals Incorporated
USD 459.62
VRTX
+2.59
0.57%
Bristol-Myers Squibb Company
USD 46.92
BMY
-0.71
-1.49%
Chugai Pharmaceutical Co., Ltd.
USD 49.30
4519.T
+0.76
1.57%
CSL Limited
USD 158.90
CSL.AX
+0.55
0.35%
GSK plc
USD 19.16
GSK.L
+0.13
0.68%
Siemens Healthineers AG
USD 55.00
SHL.DE
-0.17
-0.31%
Regeneron Pharmaceuticals, Inc.
USD 547.36
REGN
-0.38
-0.07%
Key Data
| Date | Revenue | Revenue | Gross Profit | Operating Income |
|---|
Competitors
AbbVie Inc.
USD 189.28
ABBV
-1.47
-0.77%
Novo Nordisk A/S
USD 71.08
NOVO-B.CO
+2.24
3.26%
Roche Holding AG
USD 347.79
RO.SW
+3.30
0.96%
Novartis AG
USD 123.46
NOVN.SW
+2.11
1.74%
Abbott Laboratories
USD 134.44
ABT
+0.33
0.25%
AstraZeneca PLC
USD 140.96
AZN.L
+1.64
1.18%
Merck & Co., Inc.
USD 80.93
MRK
-1.46
-1.77%
Thermo Fisher Scientific Inc.
USD 429.33
TMO
+1.57
0.37%
Amgen Inc.
USD 298.24
AMGN
+1.39
0.47%
Boston Scientific Corporation
USD 104.32
BSX
+0.69
0.67%
Pfizer Inc.
USD 25.38
PFE
+0.06
0.24%
Gilead Sciences, Inc.
USD 111.75
GILD
+0.24
0.21%
Sanofi
USD 98.03
SAN.PA
+1.08
1.11%
Vertex Pharmaceuticals Incorporated
USD 459.62
VRTX
+2.59
0.57%
Bristol-Myers Squibb Company
USD 46.92
BMY
-0.71
-1.49%
Chugai Pharmaceutical Co., Ltd.
USD 49.30
4519.T
+0.76
1.57%
CSL Limited
USD 158.90
CSL.AX
+0.55
0.35%
GSK plc
USD 19.16
GSK.L
+0.13
0.68%
Siemens Healthineers AG
USD 55.00
SHL.DE
-0.17
-0.31%
Regeneron Pharmaceuticals, Inc.
USD 547.36
REGN
-0.38
-0.07%